drugset / Trial / NCT04509323
Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage
RandomizedParallel-groupOpen-labelTreatment
Summary
1. To evaluate the effectiveness of Huperzine A injection in the treatment of brain injury in patients with hypertensive cerebral hemorrhage； 2. To evaluate the safety of Huperzine A injection in the treatment of brain injury in patients with hypertensive cerebral hemorrhage。
Timeline
- Start
- 2020-08-03
- Primary completion
- 2021-02-28
- Completion
- 2021-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Huperzine A | Traditional medicine (herbal / TCM) | 0.2 mg | Intramuscular |
Indications
No indication recorded.